TMAB Houston Headquarters
Texas Medical Center Innovation
2450 Holcombe Blvd
Suite X, Entrance 81
Houston, Texas 77021
TMAB is on a mission to develop best and first-in-class monoclonal antibodies for overcoming anti-VEGF treatment resistance in ovarian, endometrial, brain and colorectal cancers.
TMAB is on a mission to develop best and first-in-class monoclonal antibodies for overcoming anti-VEGF treatment resistance in ovarian, endometrial, brain and colorectal cancers.
ABOUT TMAB THERAPEUTICS, INC.
TMAB is enrolled in the elite Accelerator for Cancer Therapeutics and works with leading scientists, including from MD Anderson, the world’s #1 cancer research center.
TMAB’s strategic partnership with Nandi Life Sciences has accelerated our path from scientific concept to a seed stage biotechnology company because Nandi uniquely supports scientific founders in bringing to market ground-breaking technologies that address unmet medical needs of oncology patients, creating lasting value for stakeholders.
Get in touch
TMAB Investor Relations Office
The ARO on 242 West 53rd
New York, New York 10019
All Rights Reserved, TMAB Therapeutics, Inc. © 2024